TY - JOUR
T1 - Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs
AU - Pithavala, Yazdi K.
AU - Soria, Inmaculada
AU - Zimmerman, Cheryl L.
PY - 1997/11
Y1 - 1997/11
N2 - The deconvolution principle was used to evaluate the extent of absorption and first-pass elimination of selected drugs. In the first example, deconvolution of the portal blood profiles of etretinate (ET, a synthetic retinoid) indicated that there was significant gut-wall conversion of ET to acitretin (ETA, the primary metabolite of ET) during a 60-min intestinal perfusion of ET. In the second example, deconvolution was used to confirm that the extent of carbovir disappearing from the gastrointestinal lumen was matched by the extent of carbovir appearance in the portal blood. Thus, deconvolution has several important applications in the study of absorption and intestinal first-pass metabolism.
AB - The deconvolution principle was used to evaluate the extent of absorption and first-pass elimination of selected drugs. In the first example, deconvolution of the portal blood profiles of etretinate (ET, a synthetic retinoid) indicated that there was significant gut-wall conversion of ET to acitretin (ETA, the primary metabolite of ET) during a 60-min intestinal perfusion of ET. In the second example, deconvolution was used to confirm that the extent of carbovir disappearing from the gastrointestinal lumen was matched by the extent of carbovir appearance in the portal blood. Thus, deconvolution has several important applications in the study of absorption and intestinal first-pass metabolism.
UR - http://www.scopus.com/inward/record.url?scp=0030685147&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030685147&partnerID=8YFLogxK
M3 - Article
C2 - 9351902
AN - SCOPUS:0030685147
SN - 0090-9556
VL - 25
SP - 1260
EP - 1265
JO - Drug Metabolism and Disposition
JF - Drug Metabolism and Disposition
IS - 11
ER -